ATARA BIOTHERAPEUTICS, INC. Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost of $9.62 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis · last filed 2026-08-12
- 2026-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost $9.62M.
- 2026-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost $8.11M.
- 2025-12-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost $8.22M.
- 2025-09-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost $12.04M.
| Period end | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost as first filed |
|---|---|---|
| 2026-06-30 | $9.62M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $8.11M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $8.22M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $12.04M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $20.86M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $12.67M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $41.17M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $65.80M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $34.33M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $45.22M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $50.39M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $101.74M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $153.97M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $206.21M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $239.07M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $267.59M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $332.65M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $301.85M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $369.84M 10-K · filed 2023-02-08 | |
| 2021-09-30 | $355.03M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $367.94M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $433.68M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $499.05M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $326.32M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $345.69M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $212.92M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $257.08M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $280.43M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $186.93M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $231.80M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $310.92M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $363.72M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $412.82M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $403.83M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $164.79M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $196.51M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $211.34M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $230.68M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $245.84M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $278.09M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $294.32M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $303.83M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $319.51M 10-K · filed 2017-03-09 | |
| 2015-09-30 | $279.75M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $128.91M 10-Q · filed 2015-08-07 | |
| 2014-12-31 | $104.22M 10-K · filed 2016-03-04 | $82.32M 10-Q · filed 2015-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |